Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 127 points (0.8%) at 15,307 as of Tuesday, June 18, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 2,604 issues advancing vs. 474 declining with 57 unchanged. The Health Services industry currently sits up 0.4% versus the S&P 500, which is up 0.6%. Top gainers within the industry include UnitedHealth Group ( UNH), up 1.6%, Abbott Laboratories ( ABT), up 1.5% and Aetna ( AET), up 1.0%. On the negative front, top decliners within the industry include Medtronic ( MDT), down 1.50, and HCA Holdings ( HCA), down 0.79. TheStreet Ratings group would like to highlight 4 stocks pushing the industry higher today: 4. Fresenius Medical Care AG & Co. KGaA ( FMS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Fresenius Medical Care AG & Co. KGaA is up $0.34 (0.97) to $35.48 on heavy volume Thus far, 146,119 shares of Fresenius Medical Care AG & Co. KGaA exchanged hands as compared to its average daily volume of 162,900 shares. The stock has ranged in price between $35.47-$35.76 after having opened the day at $35.52 as compared to the previous trading day's close of $35.14. Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, operates in the field of dialysis care and dialysis products for the treatment of end-stage renal disease. Fresenius Medical Care AG & Co. KGaA has a market cap of $21.1 billion and is part of the health care sector. The company has a P/E ratio of 18.1, above the S&P 500 P/E ratio of 17.7. Shares are up 2.4% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Fresenius Medical Care AG & Co. KGaA a buy, no analysts rate it a sell, and 8 rate it a hold. TheStreet Ratings rates Fresenius Medical Care AG & Co. KGaA as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Fresenius Medical Care AG & Co. KGaA Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.